Literature DB >> 3622303

Calcium modulation and clinical effect. Profile of cyclandelate.

H Timmerman.   

Abstract

Since its original development as a vasodilator, cyclandelate has been shown to possess a pharmacological profile which reflects its primary mechanism of action-calcium modulation. Thus, the ability of the drug to improve the rheological properties of blood by maintaining red blood cell deformability and inhibiting platelet aggregation may be explained by its effects on the influx of extracellular calcium. Since elevated intracellular calcium concentrations are known to contribute to pathological changes in conditions of local cerebral ischaemia, the clinical implications for the use of cyclandelate in the treatment of such diseases are clear.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622303     DOI: 10.2165/00003495-198700332-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  2 in total

1.  The role of calcium in cell injury and repair: a hypothesis.

Authors:  B F Trump; I K Berezesky
Journal:  Surv Synth Pathol Res       Date:  1985

2.  Influence of hypercapnia on the cerebrovascular activities of some drugs used in the treatment of cerebral ischemia.

Authors:  D Cosnier; M Cheucle; G Rispat; G Streichenberger
Journal:  Arzneimittelforschung       Date:  1977
  2 in total
  2 in total

1.  PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Authors:  R Salvi; E Lobarinas; W Sun
Journal:  Drugs Future       Date:  2009       Impact factor: 0.148

Review 2.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.